Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome.
Kah Yong PeckNick AndrianopoulosDiem DinhLouise RobertsStephen J DuffyMartin SebastianDavid ClarkAngela BrennanErnesto OqueliAndrew E AjaniChristopher M ReidMelanie FreemanAndrew W TehPublished in: Heart (British Cardiac Society) (2020)
BB use remains high and is associated with reduced mortality. This reduction in mortality is primarily seen in those with reduced ejection fraction, but not in those with preserved ejection fraction.
Keyphrases
- ejection fraction
- acute coronary syndrome
- percutaneous coronary intervention
- aortic stenosis
- cardiovascular events
- antiplatelet therapy
- st segment elevation myocardial infarction
- coronary artery disease
- acute myocardial infarction
- st elevation myocardial infarction
- risk factors
- atrial fibrillation
- transcatheter aortic valve replacement
- angiotensin converting enzyme
- left ventricular
- coronary artery bypass